25 October 2018
Bas Bloem is professor of Neurological Movement Disorders and co-founder of the Parkinson Centrum Nijmegen (ParC) and ParkinsonNet. Bloem wants patients to take a more active role in their own care and wants to promote cooperation in healthcare: “First of all, care providers should consider their patients as partners with whom you cooperate to achieve the best possible health outcome. “Secondly, care providers have to specialize because the diagnosis and treatment of many diseases has become increasingly complex, but they should also cooperate with generalists, such as general practitioners. Thirdly, patients should be involved in important choices impacting their healthcare and should be supported in making those choices. Finally, healthcare should become more pro-active, rather than reactive: invest in a healthy lifestyle and early detection of problems before the burden of disease and the corresponding costs increase. I enjoy working on new care models and demonstrating the added value of these new models with credible scientific research.”
Bas Bloem, theme Disorders of Movement, is elected as new member of the Academia Europaea.
Bas Bloem is professor of Neurological Movement Disorders and co-founder of the Parkinson Centrum Nijmegen (ParC) and ParkinsonNet. Bloem wants patients to take a more active role in their own care and wants to promote cooperation in healthcare: “First of all, care providers should consider their patients as partners with whom you cooperate to achieve the best possible health outcome. “Secondly, care providers have to specialize because the diagnosis and treatment of many diseases has become increasingly complex, but they should also cooperate with generalists, such as general practitioners. Thirdly, patients should be involved in important choices impacting their healthcare and should be supported in making those choices. Finally, healthcare should become more pro-active, rather than reactive: invest in a healthy lifestyle and early detection of problems before the burden of disease and the corresponding costs increase. I enjoy working on new care models and demonstrating the added value of these new models with credible scientific research.”
-
Want to know more about these subjects? Click on the buttons below for more news.
Related news items

Grants for science communication at Radboudumc
22 April 2021 Scientists at the Radboudumc have received two KNAW grants, each worth 10,000 euros, for science communication. With the new fund, KNAW underlines importance of making science accessible. read more
UMD Catalist grant for Mohammad Alsady and Federica Conte
24 June 2020 They received this award to explore the potential of hiPS-derived skeletal muscle cells as model to investigate muscular pathophysiologic mechanisms in phosphoglucomutase I deficiency. read more
Bas Bloem elected as new member of the KNAW
30 April 2020 Bas Bloem is an expert in Parkinson's disease. He is also a healthcare innovator, focused on the integration of scientific research and its clinical applications. We congratulate Bas with this election. read more
Towards molecular therapies for Myotonic Dystrophy
1 October 2019 ReCognitION, a new 1.3 M€ European project under the leadership of Peter-Bram ‘t Hoen, Baziel van Engelen and Jeffrey Glennon, was kicked-off in Gent. read more
Useful new test for Parkinson's disease
28 March 2019 Diagnosing Parkinson's is not easy. In particular in the early stages, it can be difficult to distinguish Parkinson's from a group of other disorders that at first sight look identical. read more